A detailed history of Abich Financial Wealth Management LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Abich Financial Wealth Management LLC holds 1,141 shares of GILD stock, worth $102,130. This represents 0.21% of its overall portfolio holdings.

Number of Shares
1,141
Previous 2,873 60.29%
Holding current value
$102,130
Previous $197 Million 51.47%
% of portfolio
0.21%
Previous 0.13%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

SELL
$66.59 - $83.99 $115,333 - $145,470
-1,732 Reduced 60.29%
1,141 $95.7 Million
Q2 2024

Aug 14, 2024

BUY
$63.15 - $72.88 $41,300 - $47,663
654 Added 29.47%
2,873 $197 Million
Q1 2024

Jun 21, 2024

BUY
$71.58 - $87.29 $74,514 - $90,868
1,041 Added 88.37%
2,219 $163 Million
Q4 2023

Feb 13, 2024

BUY
$73.27 - $83.09 $86,312 - $97,880
1,178 New
1,178 $95.4 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $112B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Abich Financial Wealth Management LLC Portfolio

Follow Abich Financial Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abich Financial Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Abich Financial Wealth Management LLC with notifications on news.